2022
Commentary Article: Opioid use Disorder Cascade of Care Framework Design: A Roadmap
Williams AR, Johnson KA, Thomas CP, Reif S, Socías ME, Henry BF, Neighbors C, Gordon AJ, Horgan C, Nosyk B, Drexler K, Krawczyk N, Gonsalves GS, Hadland SE, Stein BD, Fishman M, Kelley AT, Pincus HA, Olfson M. Commentary Article: Opioid use Disorder Cascade of Care Framework Design: A Roadmap. Substance Abuse 2022, 43: 1207-1214. PMID: 35657670, PMCID: PMC9577537, DOI: 10.1080/08897077.2022.2074604.Peer-Reviewed Original ResearchConceptsOpioid use disorderHealth systemGold standard treatmentUnintentional overdose deathsYears of ageSpread of HIVQuality improvement effortsTreatment initiationClinical outcomesStandard treatmentOverdose deathsUse disordersUS deathsCare frameworkEarly dropoutDeathTreatmentImprovement effortsMedicationsOpioidsHIVYearsAvailable dataIndividuals
2016
New Hepatitis C Drugs Are Very Costly And Unavailable To Many State Prisoners
Beckman AL, Bilinski A, Boyko R, Camp GM, Wall AT, Lim JK, Wang EA, Bruce RD, Gonsalves GS. New Hepatitis C Drugs Are Very Costly And Unavailable To Many State Prisoners. Health Affairs 2016, 35: 1893-1901. PMID: 27702964, DOI: 10.1377/hlthaff.2016.0296.Peer-Reviewed Original ResearchConceptsHepatitis C epidemicHepatitis CC epidemicDrug discount programsLedipasvir/sofosbuvirTwelve-week courseNew hepatitis C drugsHealth care facilitiesHepatitis C drugsAntiviral medicationsCare facilitiesC drugsMedicationsSofosbuvirDiscount programPharmaceutical companiesEpidemicDepartmentDepartment of CorrectionsAntiviralsState prisonersState prisonsRelease